The Effect of Education Using the Teach-Back Method on Symptoms of Depression in Hemodialysis Patients


Acar E., AKIN EROĞLU S., BÜYÜKKILIÇ B. Z., ÖREN B., Cetinkaya H.

Hemodialysis International, 2026 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1111/hdi.70112
  • Dergi Adı: Hemodialysis International
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Anahtar Kelimeler: depression, education, hemodialysis, teach-back method
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: Recently, the Teach-Back Method has gained recognition in the literature as a promising, evidence-based strategy for patient education. Objective: This study aimed to assess the impact of individualized education delivered via the Teach-Back Method on depression levels among adult patients with kidney failure undergoing hemodialysis. Methods: A parallel-group trial with a pre-test and post-test design was conducted. The sample comprised 40 hemodialysis patients. Baseline (pre-test) data were collected from all participants. The intervention group received individualized education using the Teach-Back Method, delivered across three sessions. A post-test was administered 12 weeks after the initial assessment. Results: Pre-test depression scores were comparable between the intervention and control groups (mean = 13.35 and 13.55, respectively), reflecting mild depression. Following the intervention, the mean depression score in the intervention group decreased significantly to 6.20, indicating a reduction below the mild depression threshold. Conversely, the control group's post-test score increased to 16.40, remaining within the mild depression range. Conclusion: These findings suggest that Teach-Back education may reduce depression levels in hemodialysis patients. However, given the small sample size and relatively short follow-up period, larger studies with longer follow-up are needed to confirm these findings. Trial Registration: NCT 07069634.